AMRI's API revs up in Q2 after Gadea offsets plant closure and lower royalties
Steroid API firm Gadea Pharmaceuticals helped AMRI grow revenue in the second quarter offsetting flat royalties and the impact of the closure of its site in Holywell, Wales.